Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 11/20 | 0.76 |
| ▸ | STS | P08842 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10483706 | 0.86 | ELANE (1.00) | ELANESTSMEN1NPC1KMT2A | |
| SCHEMBL133568 | 0.86 | ELANE (0.53) | ELANEMEN1NPC1KMT2AALDH1A1 | |
| SCHEMBL9939655 | 0.86 | ELANE (0.53) | ELANEMEN1NPC1KMT2AALDH1A1 | |
| SCHEMBL285949 | 0.86 | ELANE (0.53) | ELANEMEN1NPC1KMT2AALDH1A1 | |
| SCHEMBL364405 | 0.84 | KMT2A (0.56) | ELANEKMT2APARP10ALDH1A1SRD5A2 | |
| Hydrochloric Acid SCHEMBL19834657 | 0.84 | ELANE (0.51) | ELANEMEN1NPC1KMT2AALDH1A1 | |
| Hydrochloric Acid SCHEMBL10445713 | 0.84 | ELANE (0.51) | ELANEMEN1NPC1KMT2AALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL9613925 | 0.84 | ELANE (0.51) | ELANEMEN1NPC1KMT2AALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL2037585 | 0.84 | ELANE (0.51) | ELANEMEN1NPC1KMT2AALDH1A1 | |
| SCHEMBL28281300 | 0.84 | ELANE (0.51) | ELANEMEN1NPC1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3908306-A1 | PHOSPHATASE BINDING COMPOUNDS AND METHODS OF USING SAME | Yale University (US) | 2021-11-17 | — | — | EP | claimed |
| CN-113481228-A | Microorganism unnatural amino acid introduction system and construction method | 中国药科大学 | 2021-10-08 | — | — | CN | claimed |
| WO-2020146470-A1 | Phosphatase Binding Compounds and Methods of Using Same | YALE UNIVERSITY (US) | 2020-07-16 | — | — | WO | claimed |
| US-12351857-B2 | Activity based probes | UNIVERSITY OF DUNDEE (GB) | 2025-07-08 | — | — | US | disclosed |
| US-20220267825-A1 | ACTIVITY BASED PROBES | UNIVERSITY OF DUNDEE (GB) | 2022-08-25 | — | — | US | disclosed |
| EP-4021926-A1 | ACTIVITY BASED PROBES | University of Dundee (GB) | 2022-07-06 | — | — | EP | disclosed |
| EP-3923974-A1 | IL-2 CONJUGATES AND METHODS OF USE THEREOF | Synthorx, Inc. (US) | 2021-12-22 | — | — | EP | disclosed |
| EP-3908306-A1 | PHOSPHATASE BINDING COMPOUNDS AND METHODS OF USING SAME | Yale University (US) | 2021-11-17 | — | — | EP | disclosed |
| CN-113481228-A | Microorganism unnatural amino acid introduction system and construction method | 中国药科大学 | 2021-10-08 | — | — | CN | disclosed |
| EP-3830580-A1 | BIOSENSORS FOR DETECTING ARRESTIN SIGNALING | Montana Molecular LLC (US) | 2021-06-09 | — | — | EP | disclosed |
| WO-2021038034-A1 | ACTIVITY BASED PROBES | UNIVERSITY OF DUNDEE (GB) | 2021-03-04 | — | — | WO | disclosed |
| EP-2046814-A2 | MINIMIZED SMALL PEPTIDES WITH HIGH AFFINITY FOR FACTOR VIII AND FACTOR VIII-LIKE PROTEINS | Technische Universität München (DE) | 2009-04-15 | — | — | EP | disclosed |
| WO-2008121836-A1 | COMPOUNDS AND METHODS FOR ENHANCING MHC CLASS II THERAPIES | BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2008-10-09 | — | — | WO | disclosed |
| WO-2008003707-A2 | MINIMIZED SMALL PEPTIDES WITH HIGH AFFINITY FOR FACTOR VIII AND FACTOR VIII-LIKE PROTEINS | Technische Universität München (DE) | 2008-01-10 | — | — | WO | disclosed |
| CN-1688600-A | Template-fixed peptidomimetics with antibacterial activity | POLYPHOR LTD (CH) | 2005-10-26 | — | — | CN | disclosed |
| CN-1582296-A | Template-fixed peptidomimetics as serine protease inhibitors | POLYPHOR LTD (CH) | 2005-02-16 | — | — | CN | disclosed |
| CN-1163261-C | Method of treating skin pigmentation | ���Ǿ� | 2004-08-25 | — | — | CN | disclosed |
| US-20030114362-A1 | Penta-or tetrapeptide binding to somatostatin receptors and the use of the same | NOVASPIN BIOTECH GMBH (DE) | 2003-06-19 | — | — | US | disclosed |
| WO-2002100885-A2 | A PENTA- OR TETRAPEPTIDE BINDING TO SOMATOSTATIN RECEPTORS AND THE USE OF THE SAME | NOVASPIN BIOTECH GMBH (DE) | 2002-12-19 | — | — | WO | disclosed |
| CN-1283507-A | Method of treating skin pigmentation | JOHNSON & JOHNSON CONSUMER (US) | 2001-02-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030114362-A1 | Penta-or tetrapeptide binding to somatostatin receptors and the use of the same | SSTR5, SSTR3, SCTR | ELANE 302/4885STS 1097/4885MEN1 629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.